Through a program facilitated by NCCN in December 2009, 18 oncology leaders from China met with colleagues at Memorial Sloan-Kettering Cancer Center in New York, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, and NCCN through the NCCN Global Leadership Exchange Program. The program brought together expert clinicians and administrators from some of the leading academic and research institutions in China with faculty at NCCN Member Institutions to discuss topics ranging from breast cancer clinical research to how the NCCN Clinical Practice Guidelines in Oncology™ are being adapted and implemented in China through the NCCN Guidelines China Editions.
At Memorial Sloan-Kettering Cancer Center (MSKCC) in New York, NY, the delegates from China met with Dr. Thomas J. Fahey, Senior Vice President, Clinical Program Development, Dr. Clifford Hudis, Chief, Breast Cancer Medicine Service, and Dr. Mark E. Robson, Clinical Director, Clinical Genetics Service, among others, to discuss MSKCC's approach to multidisciplinary breast cancer treatment as well as operational issues in the management of departments and medical reimbursement at the center. A session on medical oncology clinical operations addressed the clinical genetics service, key clinical research taking place at MSKCC, and the organization of international multi-center randomized controlled trials (RCTs). The visit to MSKCC also allowed the Chinese delegates to tour facilities including the Evelyn H. Lauder Breast Center.
At The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD, delegates met with Dr. Ben Park, Assistant Professor of Oncology, and Dr. Fariba Asrari, Clinical Associate in Radiation Oncology and Senior Radiation Oncologist, among others, specifically to discuss new approaches to breast cancer diagnosis and treatment in the spheres of surgical oncology, medical oncology, and radiation oncology as well as breast cancer clinical research. Chief Administrative Officer Terry Langbaum also met with the delegates and facilitated a tour of the breast center outpatient clinic, laboratory, and chemotherapy and radiation facilities.
Following these site visits, the delegation met at the NCCN headquarters to discuss the NCCN Guidelines China Editions and how this program is bringing NCCN information to clinicians in China. The visitors also received an update on current NCCN programs including clinical research and the role NCCN currently plays in clinical practice, reimbursement, and the regulatory environment. Through programs such as the China Editions and the Global Leadership Exchange, NCCN is facilitating international dialogue and discussion that seeks to improve care for patients with cancer in the United States and around the world.
The delegation from China attending the NCCN Global Leadership Exchange program included individuals from the following hospitals: